Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
07/1996
07/30/1996US5541203 Triazole antifungal agents
07/30/1996US5541202 New leukotriene-B4 Antagonists and their use as pharmaceutical agents
07/30/1996US5541200 Piperidinyl thiacyclic derivatives
07/30/1996US5541198 Antisticking agents for platelets
07/30/1996US5541196 Antiprotozoa agents
07/30/1996US5541195 1-acylpiperidine compounds
07/30/1996US5541194 Pharmaceutical compostion used to treat dementia
07/30/1996US5541192 Treating restinosis
07/30/1996US5541191 Treating pulmonary inflamation
07/30/1996US5541190 Treating benign prostatic hyperplasia, male pattern baldness, prostatic cancer, androgenic alopecia
07/30/1996US5541188 Treating muscular disorders caused by injury or disease, restoring function, striated muscle
07/30/1996US5541184 S-timolol hemihydrate treatment process
07/30/1996US5541183 Ginkgolide derivatives
07/30/1996US5541182 Benzodiazepine aryl urea derivatives
07/30/1996US5541180 Headache therapy
07/30/1996US5541178 Carbapenem antibiotic compounds
07/30/1996US5541175 Cephalosporin antibiotics
07/30/1996US5541174 Coordination compound of copper and an amino acid
07/30/1996US5541172 Controlled release systems and low dose androgens
07/30/1996US5541171 Orally administrable pharmaceutical composition
07/30/1996US5541170 Orally administrable pharmaceutical compositions
07/30/1996US5541168 Proteolytic enzyme inhibitors; degenerative diseases; respiratory, skin, genetic and gastrointestinal disorders; antiarrthritic and -inflammatory agents; genetic diseases
07/30/1996US5541165 Saliva substitute
07/30/1996US5541164 Such as cladribine, to treat e.g. rheumatoid arthritis and multiple sclerosis
07/30/1996US5541163 Renin inhibiting N-(2-amino-2-oxoethyl)butanediamide derivatives
07/30/1996US5540938 Formulations and their use in the treatment of neurological diseases
07/30/1996US5540936 Method of producing liposomes
07/30/1996US5540931 Antiinflammatory agents using lanolin, oil, polysorbates and cyclosporins
07/30/1996US5540930 Nonagglomerating suspension
07/30/1996US5540919 Method for enhancement of production of lymphokines and applications thereof
07/30/1996US5540917 Biomass lipase inhibitor useful for treating adiposity
07/30/1996US5540914 Melanogenesis, methylxanthine, tyrosine
07/30/1996US5540912 Viscous suspensions of controlled-release drug particles
07/30/1996US5540842 Method of producing an artificial kidney perfusion component for bicarbonate dialysis and the artificial kidney perfusion component
07/30/1996US5540227 Tonometer for applying fluorescein to eyes
07/30/1996CA2072509C Cyclosporin emulsion compositions for oral administration
07/30/1996CA2043440C Method of treating impotence
07/30/1996CA2027814C Treatment of hepatobiliary disease with 15-keto-prostaglandin compounds
07/30/1996CA1338500C Glycosylated amino acids and peptides
07/30/1996CA1338496C Pharmaceutically active iron complexes of 3-hydroxy-4-pyrones
07/30/1996CA1338495C Phenol substituted gem-diphosphonate derivatives, process for their preparation and pharmaceutical compositions containing them
07/30/1996CA1338494C 1,2,5,6-tetrahydropyridine oxime derivatives; process for preparing them and their use as drugs; compositions containing the same
07/30/1996CA1338493C Bicyclic aromatic derivatives; process for preparing the same and their use in cosmetics
07/30/1996CA1338491C Tricyclo compounds, a process for their production and a pharmaceutical composition containing the same
07/30/1996CA1338489C Pharmaceutical preparation containing 2,6-diamino-3-phenyl-azo-pyridine
07/27/1996CA2141126A1 Combinational drug for treating migraine and other illnesses
07/26/1996CA2167979A1 Phosphonoacetic acid derivatives and their use for treating degenerative joint disorders
07/25/1996WO1996022387A1 Diagnostic method using estrogen receptor gene polymorphisms
07/25/1996WO1996022368A1 Ribozymes targeting the retroviral packaging sequence expression constructs and recombinant retroviruses containing such constructs
07/25/1996WO1996022303A1 Therapeutic compound - fatty acid conjugates
07/25/1996WO1996022295A1 Tricyclic benzazepine vasopressin antagonists
07/25/1996WO1996022294A1 Bicyclic benzazepine derivatives as vasopressin antagonists
07/25/1996WO1996022293A1 Tricyclic benzazepine vasopressin antagonists
07/25/1996WO1996022292A1 Tricyclic vasopressin antagonists
07/25/1996WO1996022291A1 Guanine derivative
07/25/1996WO1996022290A1 Compounds having effects on serotonin-related systems
07/25/1996WO1996022288A1 GLYCOPROTEIN IIb/IIIa ANTAGONISTS
07/25/1996WO1996022287A1 Bis-sulfonamide hydroxyethylamino retroviral protease inhibitors
07/25/1996WO1996022282A1 Tricyclic benzazepine vasopressin antagonists
07/25/1996WO1996022279A1 New derivatives of glycylanilides, preparation and therapeutical application
07/25/1996WO1996022278A1 Novel farnesyl transferase inhibitors, preparation thereof and pharmaceutical compositions containing same
07/25/1996WO1996022277A1 Nitrogen mustard prodrugs with novel lipophilic protecting groups, and processes for their production
07/25/1996WO1996022112A1 Delivery of therapeutic agents by gene therapy
07/25/1996WO1996022105A1 Pharmaceutical formulations comprising a salt of clavulanic acid, vancomycin and one or more beta-lactam antibiotics
07/25/1996WO1996022101A1 Combined therapeutical treatment of hyperproliferative diseases
07/25/1996WO1996022100A1 4-aza-19-norandrostane derivatives
07/25/1996WO1996022098A1 Use of acyclic purine derivatives for treating restenosis
07/25/1996WO1996022096A1 Pharmaceutical compositions containing bisaramil inhibiting radical production and process for preparing same
07/25/1996WO1996022095A2 Use of thiazolium compounds for preventing and reversing the formation of advanced glycosylation endproducts
07/25/1996WO1996022094A1 Treatment of prostate cancer
07/25/1996WO1996022093A1 Use of 3,4-diphenyl chromans for the manufacture of a pharmaceutical composition for vasodilatory treatment or prophylaxis
07/25/1996WO1996022092A1 Use of 3,4-diphenyl chromans for the manufacture of a pharmaceutical composition for the treatment or prophylaxis of obesity
07/25/1996WO1996022091A1 Use of 3,4-diphenyl chromans for the manufacture of a pharmaceutical composition for the treatment or prophylaxis of cerebral degenerative disorders
07/25/1996WO1996022090A1 Green porphyrins as immunomodulators
07/25/1996WO1996022088A1 Anti-inflammatory eyedrops
07/25/1996WO1996022087A1 Sulfonamide-based compositions and methods
07/25/1996WO1996022086A1 MEDICINE CONTAINING β-OXO-β-BENZENEPROPANE-THIOAMIDE DERIVATIVE
07/25/1996WO1996022085A1 The use of sertraline to treat cancer patients
07/25/1996WO1996022082A1 Valaciclovir tablets containing colloidal silicon dioxide
07/25/1996WO1996022081A1 Liquid stable vitamin c compositions and delivery systems, and methods of making and uses thereof
07/25/1996WO1996022068A2 Methods and pharmaceutical compositions employing desmethylselegiline
07/25/1996WO1996022021A1 Protein hydroxylation inhibitors for fibroproliferative disorders
07/25/1996WO1996016046A3 Novel benzyl pyrimidines
07/25/1996WO1996011945A3 Cyclic depsipeptide sulfonylation, sulfenylation and phosphorylation process
07/25/1996WO1996011694A3 AROMATIC COMPOSITION BASED ON OLIBANAM COMBINED WITH A SYNERGIC AGENT (e.g. EUCALYPTOL, BARNEOL, ZINC, SALT, COPPER, SALT) AND USE THEREOF
07/25/1996WO1996009805A3 Chitosan induced immunopotentiation
07/25/1996WO1996008228A3 Derivatives of 2-amino-1,2,3,4-tetrahydro-naphthalene active on the cardiovascular system
07/25/1996WO1996006639A3 Novel drugs containing chelate-forming agents
07/25/1996WO1996005209A3 Sialic acid/fucose based medicaments
07/25/1996DE19502753A1 Neue 9H-Pyrido[3,4-b]indol-Derivate New 9H-pyrido [3,4-b] indole derivatives
07/25/1996CA2211786A1 Novel farnesyl transferase inhibitors, preparation thereof and pharmaceutical compositions containing same
07/25/1996CA2211342A1 New derivatives of glycylanilides, preparation and therapeutical application
07/25/1996CA2210885A1 Protein hydroxylation inhibitors for fibroproliferative disorders
07/25/1996CA2210718A1 Delivery of therapeutic agents by gene therapy
07/25/1996CA2210688A1 Tricyclic benzazepine vasopressin antagonists
07/25/1996CA2210682A1 Glycoprotein iib/iiia antagonists
07/25/1996CA2210632A1 Tricyclic benzazepine vasopressin antagonists
07/25/1996CA2210618A1 Ribozymes targeting the retroviral packaging sequence expression constructs and recombinant retroviruses containing such constructs
07/25/1996CA2210571A1 Bicyclic benzazepine derivatives as vasopressin antagonists
07/25/1996CA2210500A1 Therapeutic compound - fatty acid conjugates
1 ... 6895 6896 6897 6898 6899 6900 6901 6902 6903 6904 6905 6906 6907 6908 6909 6910 6911 6912 6913 6914 6915 ... 7860